Matrix metalloproteinase expression in the coronary circulation induced by coronary angioplasty

被引:73
|
作者
Hojo, Y [1 ]
Ikeda, U [1 ]
Katsuki, T [1 ]
Mizuno, O [1 ]
Fujikawa, H [1 ]
Shimada, K [1 ]
机构
[1] Jichi Med Sch, Dept Cardiol, Minami Kawachi, Tochigi 3290498, Japan
关键词
extracellular matrix; vascular remodeling; collagen; plaque;
D O I
10.1016/S0021-9150(01)00615-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent studies have revealed that matrix metalloproteinases (MMPs) play an important role in cardiovascular remodeling by degrading the extracellular matrix. We investigated changes in the expression of MMPs due to percutaneous transluminal coronary angioplasty (PTCA). We studied 47 patients with ischemic heart disease who underwent elective PTCA on isolated stenotic lesion of left coronary arteries. Twelve patients received conventional balloon angioplasty, 14 percutaneous transluminal rotational atherectomy and 21 stent implantation. Blood samples were drawn from the coronary sinus immediately before and after, as well as 4 and 24 h, after PTCA. Plasma levels of MMP-1, MMP-2, tissue inhibitor of MMP (TIMP)-1 and TIMP-2 were measured by enzyme-linked immunosorbent assay. Plasma MMP-2 activity was determined with the digestion of a specific chromogenic peptide substrate. We could observe serial changes in plasma MMP-1 levels, in the coronary circulation only in one patient, because MMP-1 levels were lower than the limit of detection in other patients. On the other hand, plasma MMP-2 levels in the coronary sinus were detectable in all subjects and increased significantly 4 and 24 It after PTCA. Plasma TIMP-1 levels also showed significant increases 4 and 24 h after PTCA, whereas TIMP-2 did not show significant changes. Plasma MMP-2/TIMP-2 ratio and MMP-2 activity in the coronary sinus showed significant increases 4 and 24 It after PTCA. A positive correlation was observed between MMP-2 levels in the coronary sinus 4 It after PTCA and late loss index 6 months after PTCA. MMP-2 levels in the coronary sinus blood were significantly higher in patients with late restenosis than in those without restenosis. PTCA induces increases in plasma MMP-2 levels and activity in the coronary circulation, which may contribute to vascular remodeling and late restenosis after PTCA. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:185 / 192
页数:8
相关论文
共 50 条
  • [41] Serum Matrix Metalloproteinase-9 Levels in Acute Coronary
    Setianto, Budi Y.
    Achmad, Agus F.
    Purnomo, Luthfan B.
    ACTA MEDICA INDONESIANA, 2014, 46 (02) : 83 - 89
  • [42] Matrix metalloproteinase genetic polymorphisms in premature coronary artery disease
    Nanni, S
    Melandri, G
    Hanemaaijer, R
    Cervi, V
    Tomasi, L
    Altimari, A
    Tricoci, P
    Melloni, C
    Branzi, A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 234A - 234A
  • [44] Correlation between matrix metalloproteinase and calcification in atherosclerotic coronary arteries
    Kieffer, P
    Giummelly, P
    Schjoth, B
    Carteaux, JP
    Villemot, JP
    Hornebeck, W
    Atkinson, J
    FASEB JOURNAL, 2000, 14 (08): : A1563 - A1563
  • [45] COLLAGEN-MATRIX REMODELING AND CORONARY CIRCULATION DYNAMICS
    KRESH, JY
    MCVEY, M
    FRASCH, F
    BROCKMAN, SK
    CLINICAL RESEARCH, 1991, 39 (03): : A680 - A680
  • [46] Markers of haemostatic activation in the coronary sinus versus peripheral circulation in the coronary artery disease. Effect of percutaneous transluminal coronary angioplasty
    Marin-Blazquez, MD
    Zuazu-Jausoro, I
    Rivera, J
    Sanchez, I
    Valdes, M
    Vicente, V
    MEDICINA CLINICA, 1998, 111 (15): : 578 - 579
  • [47] Increased expression of hemostasis markers in the coronary circulation in patients with coronary artery disease
    Hojo, Y
    Ikeda, U
    Katsuki, T
    Mizuno, O
    Shimada, K
    AMERICAN HEART JOURNAL, 2000, 139 (03) : 561 - 562
  • [48] THE EFFECT OF PERCUTANEOUS TRANS-LUMINAL CORONARY ANGIOPLASTY ON SYNTHESES OF THROMBOXANE-A2 AND PROSTACYCLIN IN CORONARY CIRCULATION
    KIMURA, Y
    KODAMA, K
    NANTO, S
    TANIURA, K
    NAKA, M
    KUZUYA, T
    YAMAGISHI, M
    TADA, M
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1985, 17 : 74 - 74
  • [49] Urinary levels of matrix metalloproteinase 9 and 2 and tissue inhibitor of matrix metalloproteinase in patients with coronary artery disease
    Fitzsimmons, Patrick J.
    Forough, Reza
    Lawrence, Mark E.
    Gantt, D. Scott
    Rajab, M. Hasan
    Kim, Hyunsun
    Weylie, Brian
    Spiekerman, A. Michael
    Dehmer, Gregory J.
    ATHEROSCLEROSIS, 2007, 194 (01) : 196 - 203
  • [50] Matrix metalloproteinase-1 and matrix metalloproteinase-12 gene polymorphisms and the outcome of coronary artery disease
    Jguirim-Souissi, Imen
    Jelassi, Awatef
    Slimani, Afef
    Addad, Faouzi
    Hassine, Majed
    Ben Hamda, Khaldoun
    Najah, Mohamed
    Maatouk, Faouzi
    Rouis, Mustapha
    Slimane, Mohamed Naceur
    CORONARY ARTERY DISEASE, 2011, 22 (06) : 388 - 393